Market Place
Sourcing Support
Pharma stocks face Q4 reality check Amid Global Headwinds
20 Apr 2026 //
INDPHARMAPOST
Aurobindo Arm Theranym Expands MSD Biologics Pact With $150-175M
16 Apr 2026 //
INDPHARMAPOST
CuraTeQ Bio Enters Into Agreement with Stada Arzneimittel AG
27 Mar 2026 //
INDPHARMAPOST
Aurobindo Arm To Acquire Additional 20% Stake In JV Firm
23 Dec 2025 //
ECONOMICTIMES
Aurobindo Pharma Aims To Break Even At China Plant By Q4 Despite
23 Nov 2025 //
ECONOMICTIMES
Aurobindo Pharma Promoters Raise $2B For Realty And Asset
14 Oct 2025 //
ECONOMICTIMES
Aurobindo Pharma Predicts China Plant EBITDA Break Even This Year
17 Aug 2025 //
ECONOMICTIMES
Aurobindo Pharma Q1 FY26 PAT Drops 10% YoY to Rs. 824 Cr
10 Aug 2025 //
INDPHARMAPOST
Aurobindo to Acquire Lannett Company for Rs. 2,185 Cr
01 Aug 2025 //
INDPHARMAPOST
Aurobindo Pharma Q4 PAT falls Marginally to Rs. 903 Cr
27 May 2025 //
INDPHARMAPOST
Aurobindo Pharma Ltd eases for fifth straight session
24 Feb 2025 //
BUSINESS STD
Aurobindo Pharma to supplies to Europe from China plant in April
17 Feb 2025 //
ECONOMICTIMES
Aurobindo To Begin EU Supplies From China Plant In April
16 Feb 2025 //
ECONOMICTIMES
Aurobindo Pharma consolidated profit declines 9.66% in the Dec 2024
07 Feb 2025 //
BUSINESS STD
Aurobindo approves acquisition of 26% stake in solar energy company
06 Feb 2025 //
BUSINESS STD
Aurobindo Pharma Q3FY25 results: PAT falls 10% to Rs 845.56 crore
06 Feb 2025 //
BUSINESS STD
Aurobindo Pharma Ltd rises for third straight session
20 Jan 2025 //
BUSINESS STD
Aurobindo Pharma Ltd slips for fifth straight session
08 Jan 2025 //
BUSINESS STD
Aurobindo Pharma Ltd up for third straight session
31 Dec 2024 //
BUSINESS STD
Aurobindo Pharma Gains 2% in Trade on December 23
23 Dec 2024 //
BUSINESS STD
Aurobindo Pharma Drops for Fifth Straight Session
13 Dec 2024 //
BUSINESS STD
Why Did Aurobindo Pharma Stock Gain 3% on November 25?
25 Nov 2024 //
BUSINESS STD
Aurobindo gains after subsidiary inks product development pact
25 Nov 2024 //
BUSINESS STD
6 pharma companies sign MoUs with Telangana for Pharma City
23 Nov 2024 //
BUSINESS STD
Aurobindo Pharma Net Profit Up 7.95% in Sept. 2024 Quarter
11 Nov 2024 //
BUSINESS STD
Aurobindo Pharma Ltd drops for fifth straight session
11 Nov 2024 //
BUSINESS STD
PM Modi To Inaugurate Penicillin-G Plant In Andhra Pradesh
22 Sep 2024 //
ECONOMIC TIMES
Aurobindo to acquire 49 pc stake in GLS Pharma for Rs 22.5 cr
20 Sep 2024 //
ECONOMICTIMES
Briefs: Medicamen Biotech, Aurobindo Pharma and Ajooni Biotech
11 Sep 2024 //
INDIANPHARMAPOST
USFDA pulls up Eugia for manufacturing lapses, data accuracy at Hyderabad plant
26 Aug 2024 //
ECONOMICTIMES
Aurobindo Pharma to commercialise China plant in third quarter of FY25: CFO
19 Aug 2024 //
ECONOMICTIMES
Aurobindo Pharma stock tanks 6% after unit gets warning letter from USFDA
16 Aug 2024 //
BUSINESS STANDARD
Aurobindo may take its injectable unit public
14 Aug 2024 //
ECONOMICTIMES
Aurobindo Pharma Q1 net profit jumps 61 pc at Rs 919 cr
11 Aug 2024 //
ECONOMICTIMES
Aurobindo gets USFDA nod for generic version of Novo Nordisk`s Vagifem
07 Aug 2024 //
ECONOMICTIMES
Aurobindo Pharma’s subsidiary acquires Ace Laboratories, UK
29 Jun 2024 //
INDIANPHARMAPOST
Aurobindo Pharma net zooms by 79% in Q4 to Rs. 907 crore
28 May 2024 //
PHARMABIZ
Aurobindo commissions 4 plants in AP including Pen-G and 6-APA facilities
01 Apr 2024 //
INDINPHARMAPOST
Aurobindo receives USFDA approval for Mometasone Furoate Monohydrate nasal spray
20 Mar 2024 //
INDIANPHARMAPOST
After a pause, Aurobindo resumes drug shipments from India plant
13 Mar 2024 //
FIERCE PHARMA
Aurobindo eyes ‘WuXi’ moment to kickstart Indian bio-CDMO sector
20 Nov 2023 //
BIO PROCESS INTERNATIONAL
Aurobindo Pharma posts Q2 FY 24 up 84% at Rs. 752 Cr
10 Nov 2023 //
INDIAN PHARMA POST
Aurobindo Pharma completes sale of Antibiotic business to Apitoria Pharma
03 Oct 2023 //
INDIAN PHARMA POST
Aurobindo puts its injectables business on the block, again
24 Aug 2023 //
ECONO MIC TIMES
Aurobindo Pharma arm gets USFDA nod for Plerixafor injection
25 Jul 2023 //
ECONOMIC TIMES
Aurobindo Pharma eyes $5-B revenue in 5 years
21 Jul 2023 //
ECONOMIC TIMES
Aurobindo Pharma arm gets USFDA nod for Sevelamer hydrochloride tablets
12 Jul 2023 //
ECONOMIC TIMES
US FDA uncovers fresh faults at India`s second-biggest drugmaker Aurobindo
29 Jun 2023 //
ECONOMIC TIMES
Aurobindo arm signs pact with Medicines Patent Pool to develop anti-cancer drug
23 Jun 2023 //
ECONOMIC TIMES
Aurobindo Pharma net dips by 12.2 per cent to Rs. 506 crore in Q4
30 May 2023 //
PHARMIWEB
Aurobindo Pharma Q4 FY23 PAT up at Rs. 506 Cr
29 May 2023 //
INDIAN PHARMA POST
Aurobindo Pharma`s consolidated net profit down 18.7% at Rs 491 Cr in Q3
09 Feb 2023 //
BUSINESS STANDARD
Tergene gets recommendation from CDSCO committee for pneumococcal 15-valent
27 Dec 2022 //
MONEYCONTROL
Aurobindo unit, Evive Biotech ink licensing pact to commercialise Ryzneuta in US
24 Nov 2022 //
ECONOMIC TIMES
Aurobindo aims to complete Rs 2000 Cr Pen-G plant in Andhra Pradesh by March`24
21 Nov 2022 //
ECONOMIC TIMES
Director`s arrest no way linked to operations: Aurobindo Pharma
11 Nov 2022 //
ECONOMIC TIMES
India`s Aurobindo Pharma says director arrested by Enforcement Directorate
10 Nov 2022 //
HEALTH ET
Dr Reddy`s, Cipla, Aurobindo units recall products in US market
23 Oct 2022 //
ECONOMIC TIMES
Particulate, labeling concerns prompt 2 separate recalls in the US
30 Sep 2022 //
FIERCEPHARMA
USFDA issues 3 observations to Aurobindo Pharma`s Unit-XI
13 Sep 2022 //
MONEYCONTROL
